Efficacy of Re-188-labelled sulphur colloid on prolongation of survival time in melanoma-bearing animals.
暂无分享,去创建一个
B. Hsieh | W. Yang | F. Knapp | F. Chen | H. E. Wang | S. Yen | Y. Ou | G. Ting | J. Whang-peng | R. Liu | W. Yang
[1] Eva Forssell-Aronsson,et al. Dosimetric comparison of radionuclides for therapy of somatostatin receptor expressing tumours , 2000 .
[2] H. Biersack,et al. Dose escalation study with rhenium-188 hydroxyethylidene diphosphonate in prostate cancer patients with osseous metastases , 2000, European Journal of Nuclear Medicine.
[3] B. Hsieh,et al. Comparison of various rhenium-188-labeled diphosphonates for the treatment of bone metastases. , 1999, Nuclear medicine and biology.
[4] B. Hsieh,et al. Effect of reaction conditions on preparations of rhenium-188 hydroxyethylidene diphosphonate complexes. , 1999, Nuclear medicine and biology.
[5] S. Mirzadeh,et al. Intratumoral injection of rhenium-188 microspheres into an animal model of hepatoma. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[6] S. Mirzadeh,et al. Rhenium‐188 microspheres: A new radiation synovectomy agent , 1998, Nuclear medicine communications.
[7] H. Maxon,et al. Rhenium-188(Sn)HEDP for treatment of osseous metastases. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[8] T. Waldmann,et al. Radioimmunotherapy targeting of HER2/neu oncoprotein on ovarian tumor using lead-212-DOTA-AE1. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[9] R. Wilkinson. Pleuroperitoneal migration of intraperitoneal phosphorus-32-chromic phosphate therapy for stage I ovarian carcinoma. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[10] B. Hsieh,et al. Radiolabelling of Lipiodol with generator-produced 188Re for hepatic tumor therapy. , 1996, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.
[11] S. Mirzadeh,et al. Processing of reactor-produced 188W for fabrication of clinical scale alumina-based 188W/188Re generators , 1994 .
[12] J. Nesland,et al. Therapeutic efficacy of the alpha-emitter 211At bound on microspheres compared with 90Y and 32P colloids in a murine intraperitoneal tumor model. , 1992, Gynecologic oncology.
[13] R. Buckman,et al. Intraperitoneal therapy of malignant ascites associated with carcinoma of ovary and breast using radioiodinated monoclonal antibody 2G3 , 1992, Gynecologic oncology.
[14] A. D. Van den Abbeele,et al. 5-[123I]iodo-2'-deoxyuridine in the radiotherapy of an early ascites tumor model. , 1991, International journal of radiation oncology, biology, physics.
[15] D. Snook,et al. Intraperitoneal yttrium-90-labeled monoclonal antibody in ovarian cancer. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] C. Coleman,et al. Alpha particle radio-immunotherapy: animal models and clinical prospects. , 1989, International journal of radiation oncology, biology, physics.
[17] A. Herbst,et al. The development of alpha-emitting radionuclide lead 212 for the potential treatment of ovarian carcinoma. , 1989, American journal of obstetrics and gynecology.
[18] B. Hsieh,et al. Ascorbic acid/saline eluant increases 188Re yields after “wet” storage of 188W/188Re generators , 1996 .
[19] R. Pattillo,et al. Phosphorus-32-chromic phosphate for ovarian cancer: I. Fractionated low-dose intraperitoneal treatments in conjunction with platinum analog chemotherapy. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[20] V. Spitzer,et al. Normal appearance and reproducibility of liver-spleen studies with Tc-99m sulfur colloid and Tc-99m microalbumin colloid. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.